NextFin News - Anthropic is in talks with banks to expand its credit facility to more than $10 billion, adding to the $2.5 billion revolving line it secured last year as the artificial-intelligence company prepares for what could be the largest initial public offering in history. The expansion, described by people familiar with the matter, would give the maker of Claude a deep cash buffer before it lists - and follows the same playbook SpaceX used ahead of its own record-setting June debut.
The scale of the planned facility is the point. A $10 billion-plus credit line for a private company is not a working-capital nicety; it is a statement that Anthropic's capital needs have outgrown what even a $65 billion equity round can comfortably cover, and that management wants to face the public markets with a balance sheet that can absorb a compute cycle that can turn on a dime.
The Deal and the Precedent
Anthropic's existing facility is a $2.5 billion, five-year revolving credit line put together in May 2025 with a syndicate of seven banks: Morgan Stanley, Barclays, Citibank, Goldman Sachs, JPMorgan, Royal Bank of Canada and Mitsubishi UFJ Financial Group. Revolvers differ from term loans in a way that matters here: the borrower does not have to draw the money on a fixed schedule, and repaid amounts can be borrowed again. That flexibility is exactly what a company facing lumpy, multi-billion-dollar compute commitments wants.
The expansion under discussion would build on that structure, pushing total committed capacity past $10 billion. Companies typically increase this type of credit capacity before an IPO, with many of the same banks also serving as underwriters for the offering. SpaceX followed the same pattern, expanding its credit facility with several of its IPO bankers about a month before its June public offering. The rocket maker raised a $20 billion bridge loan in March 2026 at an effective interest rate of 4.58 percent, according to its IPO prospectus, then went public on June 12 in a debut that raised nearly $86 billion including the underwriters' option and left it with just over $100 billion in cash.
The parallel is not cosmetic. Both companies are racing to build capital-intensive infrastructure businesses - one in orbit, one in data centers - where the cost of being short on cash is not a missed payroll but a lost generation of hardware. Anthropic's own compute commitments are visible in its contract with SpaceX: the company pays $1.25 billion a month through May 2029 for access to compute at SpaceX's Colossus facility in Memphis, a deal that SpaceX's prospectus shows includes 325,000 Nvidia chips. That is $15 billion a year in committed payments before Anthropic's own data-center buildout is counted.
"This revolving credit facility provides Anthropic significant flexibility to support our continued exponential growth," Krishna Rao, Anthropic's chief financial officer, said when the original facility closed. "The backing of these global financial institutions is a testament to the strength of our business and the resonance of our mission."
Why Debt, Not Dilution, Before an IPO
The timing is deliberate, and the arithmetic behind it is straightforward. Anthropic closed a $65 billion Series H round on May 28 at a $965 billion post-money valuation - a level that nearly doubled the company's private-market value in four months. Raising more equity now, before the IPO, would either dilute existing holders at a price below what management believes the public market will pay, or force the company to accept a valuation ceiling it would rather let public investors set.
Debt does neither. A revolving credit line adds liquidity without setting a valuation, without issuing new shares, and without resetting the comps that underwriters will use when they pitch the IPO to public investors. For a company whose private valuation has more than doubled in a matter of months, waiting for the public print is the rational move - provided the company can fund its burn in the meantime. The credit line is the bridge.
There is also a signaling dimension. Banks do not extend ten-figure credit lines to pre-IPO companies on goodwill alone. The underwriting standards, covenants, and pricing of a facility this size constitute a third-party validation of creditworthiness that sits alongside, but is distinct from, the equity story. When the roadshow begins, management can point to a syndicate of global banks willing to lend against the company's cash flows - a different and, for some investors, more conservative vote of confidence than a venture round led by growth funds.
But the signal cuts both ways if the terms are onerous. A revolver priced at a steep spread, or laden with tight covenants, would tell the market that lenders see more risk than the equity round's headline valuation suggests. The absence of disclosed terms is itself a data point: Anthropic has not commented on the talks, and neither the pricing nor the final structure has been made public.
The IPO Stakes
The credit line is a supporting act to the main event: an IPO that investors are quietly modeling at valuations well above the $965 billion private mark. The chief financial officer has begun early-stage meetings with prospective investors, according to people familiar with the discussions, though the sessions have focused on the Claude model lineup, enterprise strategy and leadership rather than on a specific valuation or financial target. The company confidentially filed its prospectus with the Securities and Exchange Commission in June, which starts the listing clock without locking the company into a date.
The private-market anchor is already extraordinary. Anthropic's revenue run rate reached $47 billion by mid-May, the company said, up from roughly $10 billion in total revenue across all of 2025. Half a dozen of the company's backers expect annualized revenue to reach between $100 billion and $120 billion before the end of the year. One investor argued that a company growing at that pace would command at least a 30-times-revenue multiple at the low end, implying a valuation above $3 trillion. These are investor calculations, not guidance from Anthropic, and senior executives have not fixed a valuation target even in private conversations.
Even at the conservative end, the offering would redefine the IPO market. SpaceX's June debut raised nearly $86 billion; an Anthropic listing at $2 trillion or more would more than double that record. The lead banks are in place - Morgan Stanley and Goldman Sachs, with JPMorgan also on the deal - and the target window has been reported as early as the autumn, with some accounts pointing to a listing as soon as the fall and others to October. Nothing is final.
Cyclical or Structural: What This Financing Actually Says
The deeper question is whether the willingness of banks to lend nine or ten figures to a pre-IPO AI company marks a structural shift in how the market finances frontier technology, or a cyclical wave of liquidity that will recede when growth normalizes.
The evidence points to structural, with a cyclical overlay. The structural case rests on three pillars. First, the asset base has changed: unlike the software companies of the 2010s, which scaled on human capital and cloud credits, frontier AI labs now commit to physical compute capacity measured in hundreds of thousands of chips and multi-year power contracts. That is infrastructure economics, and infrastructure is financed with debt. Second, the revenue base has matured: a $47 billion annualized run rate produces cash flows that a credit committee can underwrite, a sharp departure from the pre-revenue era when AI startups were financed almost exclusively with equity. Third, the competitive dynamic is durable: the companies that secure compute and capital first build model and distribution advantages that compound, which is why lenders are competing to be inside the relationship rather than pricing it as a one-off.
The cyclical overlay is the valuation multiple. A 30-times-revenue multiple on a company that is only just approaching operating profitability assumes growth rates that cannot persist indefinitely. If revenue growth slows from the current pace to something closer to the hundreds of billions in absolute terms, the multiple will compress even if the business keeps growing. The credit line is insulated from that compression - a revolver is repaid from cash flow, not marked to a revenue multiple - which is precisely why Anthropic is using it rather than issuing more equity at a peak multiple.
So the mechanism is this: equity markets set the valuation ceiling; debt markets fund the operating runway; and the company keeps the two separate so that a multiple contraction does not force it to raise equity at a down round. That separation is the structural innovation, and it is likely to become the standard template for the next wave of capital-intensive AI listings.
The Counter-Thesis
The strongest argument against this reading is that the credit line is not a sign of strength but a hedge against a funding winter. The counter-thesis runs as follows: Anthropic is locking in committed capital now because it expects the IPO window to be volatile, export controls on its most advanced models to bite into revenue, and the Department of Defense litigation - the government designated the company a supply-chain risk earlier this year - to weigh on government and defense-adjacent customers. In that view, the revolver is dry powder for a listing that may be delayed, repriced, or both.
There is real evidence for this view. Anthropic sued to reverse the blacklisting, and that litigation is still ongoing. The company's top model is priced at more than twice the level of its chief rival's flagship offering, which limits the addressable market if buyers become price-sensitive. And revenue growth, while still explosive in percentage terms, has already decelerated from the model-release cycle into a phase where each incremental billion requires more customers, more contracts, and more sales capacity.
The counter-thesis is plausible but not decisive. A company raising equity at a record valuation does not typically do so because it expects distress; it does so because it can. The credit line is additive to $65 billion of fresh equity, not a substitute for it. The more convincing read is that Anthropic is buying optionality: if the IPO window holds, the revolver stays undrawn and the company lists with a fortress balance sheet; if the window closes, the revolver keeps the compute commitments funded without a down round.
The falsifying signal is specific and observable: if Anthropic actually draws down a material portion of the facility - more than 30 percent - before the IPO prices, that would indicate the equity path is not funding the burn as expected and would shift the read from optionality to necessity. A second falsifier: if the IPO is delayed beyond the first half of next year while the credit line is drawn, the "fortress balance sheet" narrative fails.
What Comes Next
The near-term catalysts are clear. Investor meetings are underway; the SEC review of the confidential filing will determine when the public prospectus can land; and the company must decide whether to price in the autumn window or wait for clearer market conditions. The credit facility terms, when disclosed, will be the first hard read of how lenders are pricing AI risk at scale.
Short term, the story is about timing and optics: a drawn revolver before the IPO would spook investors; an undrawn one would be read as discipline. Medium term, the story is about whether revenue can reach the $100 billion to $120 billion range that investors are modeling without margin collapse from compute costs. Long term, the story is whether debt-financed AI infrastructure becomes a durable asset class or a cycle that ends in overcapacity.
The base case is an autumn or early-winter listing at a valuation above the $965 billion private mark but below the most aggressive investor models, with the credit line left largely undrawn as a backstop. The upside case is a $2 trillion-plus debut that resets the ceiling for the entire technology IPO market. The downside case is a delayed listing, a repriced round, and a drawn revolver that tells the market the growth engine needs more fuel than equity investors are willing to provide at peak multiples.
The closing judgment: Anthropic's $10 billion credit line is not the story - it is the tell. It reveals a company confident enough in its equity valuation to avoid dilution, but prudent enough to insure against the one thing no multiple can protect: running out of cash in the middle of a compute arms race. The market will learn soon enough which side of that bet was right.
Explore more exclusive insights at nextfin.ai.
